CTLA4 and metastatic melanoma: In a study of 26 patients with metastatic melanoma treated with anti-CTLA-4 monotherapy, the author reported that the baseline abundance of Faecalibacterium and other Firmicutes were associated with both treatment efficiency and irAEs, and Bacteroidetes were associated with lower treatment response and lower irAEs [164].